Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR in Manic Phase of Bipolar Disorder
NCT00521365Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- May 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in bipolar I disorder, sponsored by AstraZeneca. Started May 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00521365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521365.